Commercialization of novel soft neural interfaces

Informations projet

E-DURA

N° de convention de subvention: 790654

DOI

10.3030/790654

Projet clôturé

Date de signature de la CE 13 Juillet 2018

Date de début 1 Septembre 2018

Date de fin 29 Février 2020

Financé au titre de

• EXCELLENT SCIENCE - European Research Council (ERC)

Coût total

€ 149 994,00

Contribution de l’UE

€ 149 994,00

Coordonné par

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Switzerland

Periodic Reporting for period 1 - E-DURA (Commercialization of novel soft neural interfaces)

Période du rapport: 2018-09-01 au 2020-02-29

Résumé du contexte et des objectifs généraux du projet

The ERC POC E-DURA allowed to perform the first steps of bringing the e-dura technology from the laboratory towards the clinical markets. e-dura is a soft neurotechnology that allows to manufacture a new generation of extremely compliant implantable electrodes that can record from and/or stimulate the brain, spinal cord or nerves. This technology promises advanced diagnostics and therapies for patients suffering from trauma and neurological disorders.

The ERC POC allowed to identify a business case for the technology and a first market entry for a first product using this technology: the SOFT ECoG. The SOFT ECoG is a brain electrode array to be positioned at the surface of the cerebral cortex and designed to be implanted for a period of up to 30 days. It can be used to monitor seizures in drug-resistant epilepsy patients or to perform intra-operative neuromonitoring during brain tumor resection in order to avoid damaging critical parts of the brain.

During the ERC POC, we validated the possibility to manufacture and surgically manipulate human-scale electrodes for the brain, and initiated all the regulatory, clinical and quality work necessary to bring the SOFT ECoG to the clinic.

A start-up company, Neurosoft Bioelectronics, will now undertake these activities to bring these devices and technologies to market.